期刊文献+
共找到472篇文章
< 1 2 24 >
每页显示 20 50 100
A very high frequency index of heart rate variability for evaluation of left ventricular systolic function and prognosis in chronic heart failure patients using five-minute electrocardiogram
1
作者 Xia Liu 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2009年第4期213-217,共5页
Objective A novel index based on fi-equency-domain analysis of heart rate variability (HRV) was tested on patients with reduced left ventricular systolic function. This index, namely VHFI, was defined as the very hi... Objective A novel index based on fi-equency-domain analysis of heart rate variability (HRV) was tested on patients with reduced left ventricular systolic function. This index, namely VHFI, was defined as the very high frequency (VHF) component of the power spectrum normalized to represent its relative value in proportion to the total power minus the very low frequency component. Methods Patients (n = 130) were divided into a study group, consisting 66 patients with decreased left ventricular systolic function, and a control group, consisting 64 patients with normal heart structure and function and without severe coronary artery stenosis (〈 50%). Results VHFI in the study group was significantly higher than that in the control group (19.17 ± 13.35 vs 11.37 ± 10.77, P 〈 0.001). Cardiac events occurred in 18 patients during follow-up (33.34 i 3.26 months). Defining the positive test as VHFI =15 and negative test as VHFI 〈15, achieved a sensitivity of 57.58% and a specificity of78.13% for predicting decreased left ventricular systolic function, and achieved a sensitivity of 66.67% and a specificity of 64.29% for predicting cardiac events. Univariate Cox regression analysis showed that positive VHFI test was an independent variable in predictive cardiac events. Conclusions The results suggest that VHFI is a useful tool for quick evaluation of left ventricular systolic function and prediction of prognosis 展开更多
关键词 heart rate variability left ventricular systolic function PROGNOSIS chronic heart failure
下载PDF
Analysis of heart rate variability based on singular value decomposition entropy 被引量:2
2
作者 李世阳 杨明 +1 位作者 李存岑 蔡萍 《Journal of Shanghai University(English Edition)》 CAS 2008年第5期433-437,共5页
Assessing the dynamics of heart rate fluctuations can provide valuable information about heart status. In this study, regularity of heart rate variability (HRV) of heart failure patients and healthy persons using th... Assessing the dynamics of heart rate fluctuations can provide valuable information about heart status. In this study, regularity of heart rate variability (HRV) of heart failure patients and healthy persons using the concept of singular value decomposition entropy (SvdEn) is analyzed. SvdEn is calculated from the time series using normalized singular values. The advantage of this method is its simplicity and fast computation. It enables analysis of very short and non-stationary data sets. The results show that SvdEn of patients with congestive heart failure (CHF) shows a low value (SvdEn: 0.056±0.006, p 〈 0.01) which can be completely separated from healthy subjects. In addition, differences of SvdEn values between day and night are found for the healthy groups. SvdEn decreases with age. The lower the SvdEn values, the higher the risk of heart disease. Moreover, SvdEn is associated with the energy of heart rhythm. The results show that using SvdEn for discriminating HRV in different physiological states for clinical applications is feasible and simple. 展开更多
关键词 heart rate variability (HRV) singular value decomposition (SVD) ENTROPY congestive heart failure (CHF)
下载PDF
Multiple Scale Entropy (MPE) Estimation and Analysis of Normal and Congestive Heart Failure Subjects 被引量:1
3
作者 Chodavarapu Renu Madhavi Alevoor Gopal Krishnachar Ananth 《材料科学与工程(中英文版)》 2010年第9期66-71,共6页
关键词 充血性心力衰竭 茂金属聚乙烯 多尺度 体分析 非线性动力学 非线性分析 心脏疾病
下载PDF
The role of B-type natriuretic peptide in the evaluation of congestive heart failure patients in emergency department
4
作者 Hao Wang Tiffany Littleton +3 位作者 Sonya J. Wilson Ferran Ros Richard D. Robinson Kathleen A. Delaney 《Open Journal of Clinical Diagnostics》 2012年第2期11-17,共7页
Aim: Congestive heart failure (CHF) is a severe cardiovascular disorder seen in the Emergency Department (ED). B-type Natriuretic Peptide (BNP) is usually ordered to evaluate the CHF severity. However, it is difficult... Aim: Congestive heart failure (CHF) is a severe cardiovascular disorder seen in the Emergency Department (ED). B-type Natriuretic Peptide (BNP) is usually ordered to evaluate the CHF severity. However, it is difficult to interpret serum BNP level when different clinical entities existed. The aim of this study is to illustrate the correlation between serum BNP level and relevant clinical variables and further determine the role of serum BNP in different CHF patients. Methods: Univariate comparisons between 26 clinical variables and serum BNP level were analyzed. In order to avoid confounding factors, potential independent clinical variables were analyzed together using multivariate regression. Results: 529 CHF patients were reviewed and divided into different groups by 26 clinical variables. Serum BNP levels were found statistically significant different by univariate compareson between groups divided by 8 clinical variables that included obesity, diastolic/systolic heart failure (HF), serum blood urea nitrogen (BUN) level, serum creatinine (Cr) level, serum sodium (Na) level, patients taking loop diuretics, history of cerebrovascular accident (CVA), and history of dementia. Among all 8 clinical variables, obesity, serum BUN, Cr level, and diastolic/systolic HF had weak-to-moderate correlation effects with serum BNP level by correlation coefficient analysis. However, only obesity and dia- stolic/systolic HF were two moderately stronger clini- cal variables that can affect the serum BNP levels by multivariate regression. Analyzing CHF patients separately by obesity and diastolic/systolic HF subsets showed longer hospitalization in diastolic HF patients with relatively higher serum Cr level. In addition, poor correlation was found between serum BNP level and length of hospitalization (LOH) as well. Conclusion: High variability of serum BNP levels exists in CHF patients with weak-to-moderate correlation effects particularly on obesity and diastolic/systolic HF.It is recommended that physicians should be cautious on interpreting BNP in different CHF populations. 展开更多
关键词 congestive heart failure B-Type NATRIURETIC PEPTIDE Clinical VARIABLES Emergency DEPARTMENT
下载PDF
Modified Multiple Scale/Segment Entropy (MMPE) Analysis of Heart Rate Variability of NHH, CHF & AF Subjects
5
作者 Chodavarapu Renu Madhavi Alevoor Gopal Krishnachar Ananth 《Journal of Life Sciences》 2011年第8期593-597,共5页
Nonlinear analysis of heart rate variability (HRV) has become important as heart behaves as a complex system. In this work, the approximate entropy (ApEn) has been used as a nonlinear measure. A new concept of est... Nonlinear analysis of heart rate variability (HRV) has become important as heart behaves as a complex system. In this work, the approximate entropy (ApEn) has been used as a nonlinear measure. A new concept of estimating the ApEn in different segments of long length of the recorded data called modified multiple scale (segment) entropy (MMPE) is introduced. The idea of estimating the approximate entropy in different segments is useful to detect the nonlinear dynamics of the heart present in the entire length of data. The present work has been carried out for three cases namely the normal healthy heart (NHH) data, congestive heart failure (CHF) data and Atrial fibrillation (AF) data and the data are analyzed using MMPE techniques. It is observed that the mean value of ApEn for NHH data is much higher than the mean values for CHF data and AF data. The ApEn profiles of CHF, AF and NHH data for different segments obtained using MPE profiles measures the heart dynamism for the three different cases. Also the power spectral density is obtained using fast fourier transform (FFT) analysis and the ratio of LF/HF (low frequency/high frequency) power are computed on multiple scales/segments namely MPLH (multiple scale low frequency to high frequency) for the NHH data, CHF data and AF data and analyzed using MPLH techniques. The results are presented and discussed in the paper. 展开更多
关键词 Multiple scale/segment heart rate variability approximate entropy congestive heart failure atrial fibrillations.
下载PDF
Correlation between heart rate variables and the incidence of cardiovascular adverse events in patients with heart failure
6
作者 FU Lan-lan LI Mei-ling +1 位作者 PAN Zhi-qiong ZHOU Jia 《South China Journal of Cardiology》 CAS 2024年第3期135-141,共7页
Background Chronic heart failure(CHF)is the end-stage manifestation and main cause of death of cardiovascular system diseases.Ventricular arrhythmia is a common complication,which can increase myocardial oxygen consum... Background Chronic heart failure(CHF)is the end-stage manifestation and main cause of death of cardiovascular system diseases.Ventricular arrhythmia is a common complication,which can increase myocardial oxygen consumption,aggravate the disease,and even cause sudden death due to malignant arrhythmia.As a quantitative method to evaluate cardiac autonomic nervous function,heart rate variability is non-invasive and reproducible,and can quantify the risk associated with various cardiac and non-cardiac diseases.The purpose of this study was to analyze the correlation between heart rate variability and the incidence of cardiovascular adverse events in patients with heart failure.Methods 80 patients with heart failure who were treated in our hospital from May 2020 to May 2022 were selected as the study objects.After 3 months of follow-up,patients were divided into occurrence group(n=44)and nonoccurrence group(n=36)according to the occurrence of adverse cardiovascular events(angina pectoris,myocardial infarction,arrhythmia).The index of heart rate variability and the indicators of cardiac function in patients with heart failure was analyzed by one-way analysis of variance(ANOVA).The Key indicators of heart rate variability include standard deviation of normal RR interval(SDNN),mean standard deviation of consecutive 5-minute heartbeat interval(SDANN),square root of mean square of difference between adjacent heartbeat intervals(RMSSD),and percentage of RR intervals differing more than 50 ms from the preceding one(PNN50).The indicators of cardiac function include the New York Heart Association(NYHA)functional classification,left ventricular ejection fraction(LVEF),brain natriuretic peptide(BNP)and cardiac troponin I(c Tn I).Multivariate logistic regression was used to analyze the incidence of cardiovascular adverse events in patients with heart failure.Receiver operating characteristic(ROC)curve was used to analyze the predictive value of heart rate variability in patient outcomes.The correlation between heart rate variability and the incidence of cardiovascular adverse events was analyzed by Kendall's tau-b analysis.Results There were significant differences in SDNN,SDANN,RMSSD,PNN50,cardiac function grade,LVEF and BNP level between the two groups(P<0.05).Through logistic regression analysis,SDNN,SDANN,RMSSD and PNN50 were independent predictors for the incidence of cardiovascular adverse events(P<0.05).The areas under curve for SDNN,SDANN,RMSSD,and PNN50 predicting of the incidence of cardiovascular adverse events were 0.732,0.732,0.758,and 0.819 respectively,and the sensitivity was 77.27%,81.81%,75.00%and 65.91%,respectively.The specificity was 61.11%,61.11%,80.56%,83.33%(P<0.05),respectively.Through Kendall's tau-b analysis,the index of heart rate variability was negatively correlated with the incidence of adverse cardiovascular events in patients with prognosis(P<0.05).Conclusions Heart rate variability has predictive value for the incidence of adverse cardiovascular events in patients with heart failure.The lower the heart rate variability,the higher incidence of cardiovascular adverse events.[S Chin J Cardiol 2024;25(3):135-141] 展开更多
关键词 heart rate variability heart failure Cardiovascular events Cardiac function
原文传递
Parasympathetic Dysfunction in Black African Patients with Heart Failure:A Cross-Sectional Study in Sub-Saharan Africa
7
作者 Ba Hamadou Sylvie Ndongo Amougou +6 位作者 Ismaila Daouda Chris Nadege Nganou-Gnindjio Liliane Mfeukeu-Kuate Jerome Boombhi Ahmadou Musa Jingi Alain Menanga Samuel Kingue 《World Journal of Cardiovascular Diseases》 2020年第4期178-187,共10页
Background: Heart Failure (HF) is a major public health problem worldwide. Neurohormonal changes associated with HF are current therapeutic targets. The parasympathetic system in HF has not been well studied especiall... Background: Heart Failure (HF) is a major public health problem worldwide. Neurohormonal changes associated with HF are current therapeutic targets. The parasympathetic system in HF has not been well studied especially in black Africans. Aim: This study aimed to report on the prevalence and determinants of parasympathetic dysfunction in patients with heart failure in sub-Saharan Africa. Methods: We conducted a cross-sectional study between December 2017 and April 2018 in the outpatient and inpatient departments in two teaching hospitals in Yaounde-Cameroon. Cases were patients with HF matched with controls without HF according to age, sex, and risk factors (hypertension, diabetes, and obesity). We assessed the parasympathetic function via the Deep Breathing Test using an electrocardiograph. Results: We recruited 35 patients in each group. The mean age was 57 ± 11.68 years. Vagal dysfunction was seen in 51.4% of cases and 11.4% of controls (aOR: 10.1 [95% CI: 2.7 - 38.3], p = 0.001). This risk increased with the severity of HF-aOR: 11.8, [95% CI: 1.8 - 77.9], p = 0.01 for dyspnea stage III-IV, and aOR: 9.27, [95% CI: 1.3 - 65.3], p = 0.025) for HF with reduced Ejection fraction. This risk was not associated with the classic cardiovascular risk factors. Conclusion: Parasympathetic dysfunction as assessed with the Deep Breathing Test was seen in over half of the patients with HF and this was associated with the severity and type of HF. 展开更多
关键词 heart failure Parasympathetic Dysfunction heart rate variability Deep Breathing Test
下载PDF
Characterization of Congestive Heart Failure by the Pattern of Diurnal Rhythm Based on Heart Rate Variability
8
作者 WANG Zhi-gang ZHANG Zheng-guo PENG Yi 《Chinese Journal of Biomedical Engineering(English Edition)》 CAS 2022年第2期47-55,共9页
The impaired autonomic nervous system(ANS) has a close relationship to morbidity and mortality for congestive heart failure(CHF). This study is aimed to investigate the possibility to characterize CHF by the pattern o... The impaired autonomic nervous system(ANS) has a close relationship to morbidity and mortality for congestive heart failure(CHF). This study is aimed to investigate the possibility to characterize CHF by the pattern of diurnal rhythm based on heart rate variability(HRV). Two datasets of CHF(n=44) were from Physio Net. And the datasets of the normal from THEW(n=189). Two 2 h episodes representing day and night in resting state were selected in each Holter record. Measures concerning time domain, AR model-based analysis, symbol dynamic analysis, and non-Gaussian indexes(λ) were calculated in each episode. The diurnal rhythm was represented by the ratio of an index in the day to that at night. Results demonstrated different patterns of diurnal rhythm among the normal, mild CHF(NYHAI-Ⅱ) and severe CHF(NYHA Ⅲ-Ⅳ),reflecting the changes in sympathetic and vagal interaction from reciprocal function to accentuated antagonism due to CHF. Furthermore, using RRIn,(LFnu)d/(LFnu)nand λd/λn,the sensitivity and specificity for discriminating the normal and CHF reached 95.45%and 95.24%;And for discriminating between mild CHF and severe CHF were 84.38%and 91.67%. Our proposed method is promising in assessing the ANS state and monitoring therapeutic effects for CHF patients. 展开更多
关键词 heart rate variability congestive heart failure diurnal rhythm
原文传递
射血分数保留型心力衰竭患者心率变异性与左心室僵硬度的相关性
9
作者 梁仪 徐良洁 王春靓 《实用心电学杂志》 2024年第5期433-437,共5页
目的筛选反映射血分数保留型心力衰竭(heart failure with preserved ejection fraction,HFpEF)患者左心室僵硬度的敏感心率变异性(heart rate variability,HRV)指标,并评价其对HFpEF患者的预后评估价值。方法选取150例左心室射血分数(L... 目的筛选反映射血分数保留型心力衰竭(heart failure with preserved ejection fraction,HFpEF)患者左心室僵硬度的敏感心率变异性(heart rate variability,HRV)指标,并评价其对HFpEF患者的预后评估价值。方法选取150例左心室射血分数(LVEF)正常的患者,行24 h动态心电图及常规超声心动图检查。将入选患者分成正常对照组(68例)和HFpEF组(82例)。采用受试者工作特征曲线分析,筛选HRV指标中能反映HFpEF患者左心室僵硬度的敏感指标,并对主要终点事件进行随访。结果在HRV指标中,SDANN预测HFpEF的曲线下面积最大,达0.68(P<0.01),cut-off值90 ms。SDANN与左心室舒张期室壁应变呈负相关;SDANN越高,左心室僵硬度就越高。根据SDANN的cut-off值,HFpEF患者被分为高SDANN组(cut-off值≥90 ms,44例)和低SDANN组(cut-off值<90 ms,38例)。低SDANN组左心室僵硬度较低。生存曲线分析显示,高SDANN组的主要不良心脏事件发生率和全因死亡率较低SDANN组显著升高(P<0.05)。结论SDANN可作为HFpEF患者临床诊断及预后评估的敏感指标。 展开更多
关键词 心率变异性 左心室僵硬度 射血分数保留型心力衰竭 动态心电图
下载PDF
探讨沙库巴曲缬沙坦联合曲美他嗪治疗慢性充血性心力衰竭的临床疗效及安全性
10
作者 于珂 《中国实用医药》 2024年第8期99-102,共4页
目的探讨沙库巴曲缬沙坦、曲美他嗪联用治疗慢性充血性心力衰竭的疗效及安全性。方法以76例慢性充血性心力衰竭患者为研究对象,按抽签法分为甲组及乙组,每组38例。甲组给予依那普利+曲美他嗪治疗,乙组给予沙库巴曲缬沙坦+曲美他嗪治疗... 目的探讨沙库巴曲缬沙坦、曲美他嗪联用治疗慢性充血性心力衰竭的疗效及安全性。方法以76例慢性充血性心力衰竭患者为研究对象,按抽签法分为甲组及乙组,每组38例。甲组给予依那普利+曲美他嗪治疗,乙组给予沙库巴曲缬沙坦+曲美他嗪治疗。比较两组患者的治疗效果,心功能指标[左心室射血分数(LVEF)、N末端脑钠肽前体(NT-proBNP)水平及6 min步行试验距离(6MWD)、左心室舒张末期内径(LVEDD)],不良反应发生率及住院时间。结果乙组治疗总有效率97.37%高于甲组的81.58%,差异具有统计学意义(χ^(2)=5.0294,P=0.0249<0.05)。两组治疗前的LVEF、NT-proBNP、6MWD、LVEDD比较,差异无统计学意义(P>0.05);乙组治疗后的LVEF(51.27±5.65)%高于甲组的(47.84±5.25)%、NT-proBNP(867.87±66.56)pg/ml低于甲组的(911.26±76.98)pg/ml、6MWD(366.73±55.68)m长于甲组的(314.54±65.65)m、LVEDD(53.12±5.23)mm小于甲组的(56.76±5.78)mm,差异具有统计学意义(P<0.05)。乙组不良反应发生率低于甲组,但差异无统计学意义(P>0.05)。乙组住院时间(8.34±2.17)d短于甲组的(12.90±2.89)d,差异具有统计学意义(P<0.05)。结论沙库巴曲缬沙坦联用曲美他嗪治疗慢性充血性心力衰竭疗效确切,同时对心脏功能有明显的改善,是一种具有较好临床应用价值的治疗方案。 展开更多
关键词 慢性充血性心力衰竭 沙库巴曲缬沙坦 曲美他嗪 心功能
下载PDF
小剂量多巴胺治疗老年慢性充血性心力衰竭的效果
11
作者 温冬梅 《中外医学研究》 2024年第29期127-130,共4页
目的:探讨小剂量多巴胺治疗老年慢性充血性心力衰竭的效果。方法:从2021年1月—2022年12月三明市第二医院心血管内科收治的老年慢性充血性心力衰竭病例中纳入80例展开研究。根据随机数表法将其分为观察组、对照组,各40例。所有患者予以... 目的:探讨小剂量多巴胺治疗老年慢性充血性心力衰竭的效果。方法:从2021年1月—2022年12月三明市第二医院心血管内科收治的老年慢性充血性心力衰竭病例中纳入80例展开研究。根据随机数表法将其分为观察组、对照组,各40例。所有患者予以常规治疗,对照组给予注射用重组人脑利钠肽联合左西孟旦,观察组在对照组基础上给予小剂量多巴胺。比较两组临床疗效,治疗前后相关指标及时间指标。结果:总有效率经对比观察组病例更高,治疗后,两组24 h尿量升高,心率、呼吸频率、氨基末端脑利钠肽前体(NT-proBNP)均降低,观察组24 h尿量、心率、NT-proBNP等指标均低于对照组,心力衰竭好转时间和住院时间中,观察组短于对照组,差异有统计学意义(P<0.05)。结论:小剂量多巴胺适用于慢性充血性心力衰竭的老年患者的治疗需求,可对患者的24 h尿量、心率指标有明显改善作用,还能提高疗效,缩短恢复时间。 展开更多
关键词 小剂量多巴胺 老年 慢性充血性心力衰竭 24h尿量 心率
下载PDF
入院时24 h心率变异性与慢性心力衰竭病人低血压的关系 被引量:1
12
作者 付春生 胡小龙 李雪翔 《中西医结合心脑血管病杂志》 2024年第10期1835-1840,共6页
目的:探讨入院时24 h心率变异性与慢性心力衰竭(CHF)病人住院期间发生低血压的关系。方法:选取2019年5月—2022年7月我院收治的CHF病人作为研究对象,入院当日采用24 h动态心电图测定病人心率变异性,根据住院期间病人低血压发生情况将病... 目的:探讨入院时24 h心率变异性与慢性心力衰竭(CHF)病人住院期间发生低血压的关系。方法:选取2019年5月—2022年7月我院收治的CHF病人作为研究对象,入院当日采用24 h动态心电图测定病人心率变异性,根据住院期间病人低血压发生情况将病人分为发生组与未发生组。比较两组一般资料、心脏超声指标及入院时24 h心率变异性;采用Pearson法分析发生组病人24 h心率变异性与血压的相关性;采用Logistic回归分析24 h心率变异性与CHF病人发生低血压的关系;绘制受试者工作特征(ROC)曲线,分析24 h心率变异性对CHF病人住院期间发生低血压的预测价值。结果:共纳入112例CHF病人,其中男61例,女51例;年龄57~79(68.17±2.98)岁;病人住院期间低血压发生率为14.29%。发生组入院时24 h窦性R-R间期总体标准差(SDNN)、正常相邻窦性R-R间期差值均方根(rMSSD)、正常相邻R-R间期差值>50 ms百分比(pNN50)、低频(LF)、LF/高频(HF)低于未发生组,差异均有统计学意义(P<0.01)。Pearson相关性分析显示,发生组入院时24 h心率变异性指标SDNN、rMSSD、pNN50、LF、LF/HF与发生低血压时收缩压、舒张压均呈正相关(P<0.05)。Logistic回归分析结果显示,入院时rMSSD、pNN50、LF/HF是CHF病人住院期间发生低血压的影响因素(P<0.05)。ROC曲线分析显示,入院时SDNN、rMSSD、pNN50、LF、LF/HF预测CHF病人住院期间发生低血压的ROC曲线下面积(AUC)>0.70,具有一定的预测价值,联合预测的AUC>0.90,预测价值高。结论:24 h心率变异性是CHF病人住院期间发生低血压的影响因素,可预测CHF病人住院期间低血压的发生。 展开更多
关键词 慢性心力衰竭 低血压 24 h心率变异性
下载PDF
耳穴贴压联合新四联疗法治疗心衰加重的疗效观察
13
作者 雷巧灵 李擎虎 《新疆医科大学学报》 CAS 2024年第6期895-900,共6页
目的探讨耳穴贴压联合新四联疗法治疗心衰加重的疗效。方法采用随机数字表法将心衰加重患者120例分成对照组和试验组,各60例。对照组实施新四联疗法,试验组在对照组治疗基础上加用耳穴贴压,均治疗2周。比较两组六分钟步行试验(6 minutes... 目的探讨耳穴贴压联合新四联疗法治疗心衰加重的疗效。方法采用随机数字表法将心衰加重患者120例分成对照组和试验组,各60例。对照组实施新四联疗法,试验组在对照组治疗基础上加用耳穴贴压,均治疗2周。比较两组六分钟步行试验(6 minutes walk test,6MWT)结果、运动峰摄氧量(Peak oxygen uptake,PVO2)、每搏耗氧量(Oxygen consumption/heart rate,VO2/HR)、正常窦性心搏RR间期标准差(Standard deviation of NN intervals,SDNN)、全程相邻窦性心搏RR间期差值均方根(Root mean square successive differences be-tween successive R-R intervals,RMSSD)、低频功率(Low frequencies,LF)、高频功率(High fre-quencies,HF)、氨基末端脑钠肽前体(N-terminal pro-B-type natriuretic peptide,NT-proBNP)、肾素(Plasma renin activity,PRA)、血管紧张素Ⅱ(AngiotensinⅡ,AngⅡ)、醛固酮(Aldosterone,ALD)水平。结果试验组治疗总有效率为93.33%,高于对照组的80.00%(P<0.05)。与治疗前比较,治疗后2周,两组PVO2、VO2/HR、6MWT、SDNN、RMSSD、LF及HF均升高,且试验组高于对照组(P<0.05)。与治疗前比较,治疗后2周,两组NT-proBNP、PRA、AngⅡ及ALD均下降,且试验组低于对照组(P<0.05)。结论耳穴贴压联合新四联疗法可有效改善心衰加重患者运动耐量、心率变异性,调节神经激素,降低NT-proBNP水平,临床疗效优于单一新四联疗法。 展开更多
关键词 耳穴贴压 新四联疗法 心衰加重 心率变异性 运动耐量 神经激素
下载PDF
慢性心力衰竭患者血清miR-122和miR-558水平表达与心功能及心率变异性的相关性研究
14
作者 林艳 但汉良 +3 位作者 余扬 高鹏 黄继良 白杨 《现代检验医学杂志》 CAS 2024年第3期37-41,114,共6页
目的探讨慢性心力衰竭(chronic heart failure,CHF)患者血清微小RNA-122(miR-122)和微小RNA-558(miR-558)水平表达与心功能及心率变异性的关系。方法收集2019年1月~2022年1月武汉市东西湖区人民医院收治的100例慢性心力衰竭患者作为研究... 目的探讨慢性心力衰竭(chronic heart failure,CHF)患者血清微小RNA-122(miR-122)和微小RNA-558(miR-558)水平表达与心功能及心率变异性的关系。方法收集2019年1月~2022年1月武汉市东西湖区人民医院收治的100例慢性心力衰竭患者作为研究组,同期在该院进行体检的健康者100例作为对照组。采用实时荧光定量PCR法检测两组血清miR-122和miR-558表达水平;比较两组心率变异性指标及心功能指标;采用Pearson法分析慢性心力衰竭患者血清miR-122,miR-558表达水平与心率变异性指标、心功能指标的相关性;用Logistic回归分析影响慢性心力衰竭的危险因素。结果与对照组相比,慢性心力衰竭患者血清miR-122(0.86±0.19 vs 1.07±0.16)及心率变异性指标、左室射血分数(LVEF)均明显降低(t=3.844~15.448),miR-558(1.28±0.27 vs 1.02±0.12)表达水平及左室舒张末期容积指数(LVEDVI)、左室收缩末期容积指数(LVESVI)均明显升高(t=6.794~9.358),差异具有统计学意义(均P<0.05);不同心功能分级I,II级组患者血清miR-122(1.19±0.23,1.04±0.21)表达水平显著高于III,IV级组(0.68±0.16,0.53±0.15),miR-558(0.93±0.24,1.21±0.26)表达水平显著低于III,IV级组(1.42±0.27,1.64±0.29),差异具有统计学意义(qmiR-122=3.751~14.568,qmiR-558=3.929~11.194,均P<0.05)。慢性心力衰竭患者血清miR-122与心率变异性指标、LVEF均呈正相关性(r=0.337~0.573),与LVEDVI,LVESVI呈负相关性(r=-0.385,-0.323),血清miR-558与心率变异性指标、LVEF均呈负相关性(r=-0.646~-0.246),与LVEDVI,LVESVI呈正相关性(r=0.528,0.547);血清miR-122[OR(95%CI)=0.528(0.328~0.850)],miR-558[OR(95%CI)=2.845(1.364~5.933)]是慢性心力衰竭的影响因素(P<0.05)。结论慢性心力衰竭患者血清miR-122,miR-558表达水平与心功能、心率变异性密切相关,且血清miR-122和miR-558是慢性心力衰竭的影响因素。 展开更多
关键词 慢性心力衰竭 微小RNA-122 微小RNA-558 心功能 心率变异性
下载PDF
益心汤治疗慢性心力衰竭疗效观察及对肾素-血管紧张素-醛固酮系统的影响 被引量:1
15
作者 李仁堂 宋孝祖 张玉镇 《新中医》 CAS 2024年第2期63-67,共5页
目的:观察益心汤治疗慢性心力衰竭(CHF)的临床疗效及对肾素-血管紧张素-醛固酮系统(RAAS)的影响。方法:将纳入的116例CHF患者按随机数字表法分为观察组和对照组各58例。对照组给予常规西药治疗,观察组在对照组基础上加用益心汤治疗。于... 目的:观察益心汤治疗慢性心力衰竭(CHF)的临床疗效及对肾素-血管紧张素-醛固酮系统(RAAS)的影响。方法:将纳入的116例CHF患者按随机数字表法分为观察组和对照组各58例。对照组给予常规西药治疗,观察组在对照组基础上加用益心汤治疗。于治疗8周后评定临床疗效,并比较2组治疗前后心功能指标[左室射血分数(LVEF)、每搏输出量(SV)、心输出量(CO)]、心率变异性(HRV)指标[4 h内正常R-R间期标准差(SDNN)、24 h相邻正常的R-R间期差值均方的平方根(RMSSD)及相邻NN间期之差>50 ms的个数占总窦性心搏个数的百分比(PNN50)]、RAAS指标[血管紧张素-Ⅱ(Ang-Ⅱ)、醛固酮(ALD)、肾素活性(PRA)]水平。结果:治疗后,观察组总有效率为93.10%,对照组为77.59%,2组比较,差异有统计学意义(P<0.05)。治疗后,2组LVEF、SV、CO水平均较治疗前升高(P<0.05),且观察组3项指标均高于对照组(P<0.05)。治疗后,2组SDNN、RMSSD、PNN50水平均较治疗前升高(P<0.05),且观察组上述3项指标均高于对照组(P<0.05)。治疗后,2组Ang-Ⅱ、ALD、PRA水平均较治疗前降低(P<0.05),且观察组上述3项指标均低于对照组(P<0.05)。结论:益心汤联合常规西医治疗CHF疗效显著,可有效降低患者RAAS活性,改善HRV,提高其心功能。 展开更多
关键词 慢性心力衰竭 益心汤 心率变异性 心功能 肾素-血管紧张素-醛固酮系统
下载PDF
冠心病合并急性心力衰竭患者心率变异的表达与心功能及预后的相关性
16
作者 于艳 付德华 方超 《中国循证心血管医学杂志》 2024年第6期730-732,738,共4页
目的探讨冠状动脉粥样硬化性心脏病(冠心病)合并急性心力衰竭患者心率变异的表达与心功能及预后的相关性。方法选择2020年1月至2022年1月于牡丹江心血管病医院收治的冠心病合并急性心力衰竭患者63例进行研究,作为病例组;另选取同期我院... 目的探讨冠状动脉粥样硬化性心脏病(冠心病)合并急性心力衰竭患者心率变异的表达与心功能及预后的相关性。方法选择2020年1月至2022年1月于牡丹江心血管病医院收治的冠心病合并急性心力衰竭患者63例进行研究,作为病例组;另选取同期我院未合并冠心病的急性心力衰竭患者50例,作为急性心力衰竭组;并选取同期我院健康体检者50例作为对照组。根据未发生心脏不良事件为预后良好组(45例),发生心脏不良事件为预后不良组(18例);分析三组患者心率变异水平变化情况,并分析其与心功能及预后的关系。结果病例组患者R-R间期标准差(SDNN)、相邻正常心动周期差值的均方根(rMSSD)、低频分量(LF)及高频分量(HF)水平显著低于急性心力衰竭组和对照组,LF/HF显著高于急性心力衰竭组和对照组,急性心力衰竭组患者SDNN、rMSSD、LF及HF水平显著低于对照组,LF/HF显著高于对照组患者(P<0.05)。NYHA心功能Ⅱ级患者SDNN、rMSSD、LF及HF水平显著高于心功能Ⅲ级、Ⅳ级患者,LF/HF显著低于心功能Ⅲ级、Ⅳ级患者,心功能Ⅲ级患者SDNN、rMSSD、LF及HF水平显著高于心功能Ⅳ级患者,LF/HF显著低于心功能Ⅳ级患者(P<0.05)。预后良好组SDNN、rMSSD、LF及HF水平显著高于预后不良组,LF/HF显著低于预后不良组(P<0.05);Spearman相关系数分析显示,SDNN、rMSSD、LF及HF与冠心病合并急性心力衰竭患者的心功能及预后之间呈负相关,LF/HF与冠心病合并急性心力衰竭患者心功能及预后之间呈正相关(P<0.05)。结论冠心病合并急性心力衰竭心率变异水平表达异常,且与心功能及预后之间关系密切,有望为冠心病合并急性心力衰竭的预防和治疗开辟新思路。 展开更多
关键词 冠心病 急性心力衰竭 心率变异 心功能
下载PDF
OSAHS对心力衰竭患者心功能、心率变异性及预后的影响
17
作者 王巧 孙芳 崔丽娜 《中国循证心血管医学杂志》 2024年第2期221-223,226,共4页
目的探讨阻塞性睡眠呼吸暂停低通气综合征(OSAHS)对心力衰竭(心衰)患者心功能、心率变异性及预后的影响。方法选择2021年3月至2024年3月于青岛市市立医院收治的140例急性心衰患者进行研究,根据患者是否合并OSAHS分为OSAHS组(n=59)和非OS... 目的探讨阻塞性睡眠呼吸暂停低通气综合征(OSAHS)对心力衰竭(心衰)患者心功能、心率变异性及预后的影响。方法选择2021年3月至2024年3月于青岛市市立医院收治的140例急性心衰患者进行研究,根据患者是否合并OSAHS分为OSAHS组(n=59)和非OSAHS组(n=81)。比较两组患者睡眠呼吸暂停低通气指数(AHI)、夜间最低血氧饱和度(SaO_(2))、左室射血分数(LVEF)、脑钠肽(BNP)、全部窦性心搏RR间期的标准差(SDNN)、RR间期平均值的标准差(SDANN)、相邻RR间期差值的均方根(RMSSD)、相邻NN间期之差>50 ms的个数所占总窦性心博个数的百分比(PNN50),并比较其预后情况。结果OSAHS组AHI、BNP均高于非OSAHS组,夜间最低SaO_(2)、LVEF均低于非OSAHS组,差异有统计学意义(P<0.05);OSAHS组SDNN、SDANN、RMSSD、PNN50均低于非OSAHS组(P<0.05);随访显示,OSAHS组不良心血管事件发生率高于非OSAHS组,差异有统计学意义(P<0.05)。结论OSAHS可影响心衰患者的心功能、心率变异性、短期预后,临床应予以关注。 展开更多
关键词 心力衰竭 睡眠呼吸暂停低通气指数 心功能 心率变异性 预后
下载PDF
重组人脑利钠肽联合沙库巴曲缬沙坦治疗对冠心病心力衰竭患者心率变异性和预后的影响
18
作者 刘建军 《中外医学研究》 2024年第24期17-20,共4页
目的:探讨冠心病心力衰竭患者联合应用重组人脑利钠肽、沙库巴曲缬沙坦治疗效果以及对心率变异性、预后的影响。方法:选取2020年9月—2022年9月神木市医院收治的120例冠心病心力衰竭患者作为研究对象,按随机数表法分为对照组(n=60,单用... 目的:探讨冠心病心力衰竭患者联合应用重组人脑利钠肽、沙库巴曲缬沙坦治疗效果以及对心率变异性、预后的影响。方法:选取2020年9月—2022年9月神木市医院收治的120例冠心病心力衰竭患者作为研究对象,按随机数表法分为对照组(n=60,单用沙库巴曲缬沙坦治疗)和观察组(n=60,联合应用沙库巴曲缬沙坦、重组人脑利钠肽治疗)。比较两组疗效、心率变异性、心肌损伤指标、不良心血管事件、再入院率、不良反应情况。结果:观察组临床治疗效率比对照组高,差异有统计学意义(P<0.05)。治疗前,两组心率变异性、心肌损伤指标比较,差异无统计学意义(P>0.05);治疗后,两组低频分量(LF)、高频分量(HF)升高,LF/HF、乳酸脱氢酶(LDH)、肌红蛋白(Mb)、N末端脑钠肽前体(NT-proBNP)降低,且观察组LF、HF比对照组高,LF/HF、LDH、Myo、NT-proBNP比对照组低,差异有统计学意义(P<0.05);进行3个月动态随访,观察组不良心血管事件发生率与再入院率比对照组低,差异有统计学意义(P<0.05);观察组头晕嗜睡、肌酐升高、乏力、恶心、肌肉痛等不良反应与对照组比较,差异无统计学意义(P>0.05)。结论:冠心病心力衰竭患者应用沙库巴曲缬沙坦治疗基础上加用重组人脑利钠肽,能够显著改善心率变异,减轻心肌损伤,降低不良心血管事件,提高临床疗效,并且未发生严重不良反应。 展开更多
关键词 冠心病 心力衰竭 重组人脑利钠肽 沙库巴曲缬沙坦 心率变异性 再入院率
下载PDF
养心健脾汤对心力衰竭患者的疗效及对其心率变异性、血清因子的影响
19
作者 冯莉 邓华夫 周先炎 《牡丹江医学院学报》 2024年第4期40-43,共4页
目的研究养心健脾汤对心力衰竭(heart failure,HF)患者的疗效及心率变异性、血清因子的影响。方法选取2022年1月至2023年10月我院收治的100例HF患者为研究对象,根据治疗方案分为对照组和研究组,各50例。对照组采用曲美他嗪治疗,研究组... 目的研究养心健脾汤对心力衰竭(heart failure,HF)患者的疗效及心率变异性、血清因子的影响。方法选取2022年1月至2023年10月我院收治的100例HF患者为研究对象,根据治疗方案分为对照组和研究组,各50例。对照组采用曲美他嗪治疗,研究组在对照组基础上加用养心健脾汤治疗。比较两组临床疗效、治疗前后中医证候积分、心率变异性指标[正常窦性心搏间期标准差(SDNN)、正常相邻窦性心搏间期差值的均方根(RMSSD)、全程每5 min NN节段的窦性RR间期标准差(SDANN)、相邻窦性心搏间期差值>50 ms心搏数百分比(PNN50)]、血清细胞因子[超敏C反应蛋白(hs-CRP)、B型脑利钠肽(BNP)、组蛋白脱乙酰酶2(HDAC2)、分泌型卷曲相关蛋白2(SFRP2)]水平、不良反应发生率。结果研究组临床总有效率(96.00%)高于对照组(82.00%)(P<0.05);治疗1个月后,研究组水肿、气喘、心悸、畏寒肢冷评分低于对照组(P<0.05);治疗1个月后,研究组SDNN、RMSSD、SDANN、PNN50高于对照组(P<0.05);治疗1个月后,研究组血清hs-CRP、BNP、HDAC2水平低于对照组,SFRP2水平高于对照组(P<0.05);研究组不良反应总发生率(12.00%)与对照组(8.00%)相比,差异无统计学意义(P>0.05)。结论采用养心健脾汤与曲美他嗪联合治疗可有效促进HF患者心率变异性改善,缓解炎症状态及临床症状,增强疗效,安全性良好。 展开更多
关键词 心力衰竭 养心健脾汤 曲美他嗪 疗效 心率变异性
下载PDF
沙库巴曲缬沙坦联合环磷腺苷葡胺对老年慢性心力衰竭患者心率变异性及心功能的影响
20
作者 田茂婷 朱应华 《中外医疗》 2024年第3期104-107,共4页
目的探讨沙库巴曲缬沙坦联合环磷腺苷葡胺对老年慢性心力衰竭(Chronic Heart Failure,CHF)患者心率变异性及心功能的影响。方法方便选取2021年3月—2023年5月贵州省纳雍县人民医院收治的68例老年CHF患者作为研究对象,按照简单随机抽样... 目的探讨沙库巴曲缬沙坦联合环磷腺苷葡胺对老年慢性心力衰竭(Chronic Heart Failure,CHF)患者心率变异性及心功能的影响。方法方便选取2021年3月—2023年5月贵州省纳雍县人民医院收治的68例老年CHF患者作为研究对象,按照简单随机抽样法分为两组。对照组(n=34)给予环磷腺苷葡胺治疗,观察组(n=34)加用沙库巴曲缬沙坦。对比两组心率变异性、心功能指标、不良反应。结果治疗后,观察组的RR间期平均值标准差[(80.95±8.14)ms]、全部窦性心搏RR间期的标准差[(86.51±6.44)ms]、相邻NN之差>50 ms的个数占总窦性心搏个数的百分比[(12.41±1.19)%]均高于对照组,差异有统计学意义(t=3.947、2.894、8.281,P均<0.05);观察组的左心室收缩末期容积[(141.21±14.99)mL]、左心室舒张末期容积[(214.88±19.73)mL]均低于对照组,左心室射血分数[(43.02±4.05)%]高于对照组,差异有统计学意义(t=3.419、2.040、6.623,P均<0.05);两组不良反应发生率对比,差异无统计学意义(P>0.05)。结论在老年CHF患者中应用沙库巴曲缬沙坦联合环磷腺苷葡胺治疗效果显著,能够改善心功能指标,控制心率变异性,且药物安全性良好。 展开更多
关键词 慢性心力衰竭 老年 沙库巴曲缬沙坦 环磷腺苷葡胺 心率变异性 心功能
下载PDF
上一页 1 2 24 下一页 到第
使用帮助 返回顶部